Mapping the maturation of TCM as an adjuvant to radiotherapy
This large-scale bibliometric analysis of nearly 70,000 publications from 2000 to 2025 reveals that Traditional Chinese Medicine as an adjuvant to radiotherapy has matured through cyclical evolution and thematic specialization toward patient-centered, mechanistic research, while simultaneously exhibiting a pervasive, system-wide positive reporting bias across all dimensions of the field.
Original paper licensed under CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Imagine the world of cancer treatment as a massive, bustling construction site. For decades, Radiotherapy has been the heavy machinery—powerful, essential, and the main tool for tearing down tumors. But heavy machinery can be rough on the workers (the patients), causing fatigue, pain, and other side effects.
Enter Traditional Chinese Medicine (TCM). Think of TCM as the specialized support crew: the medics, the comfort specialists, and the maintenance team. They don't replace the heavy machinery; they work alongside it to make the job smoother and the workers feel better.
This paper is like a giant, 25-year time-lapse video of that construction site. The authors looked at nearly 70,000 research papers (a massive library of blueprints and reports) to see how this "support crew" has grown, changed, and organized itself over the last quarter-century.
Here is the story of what they found, broken down into simple parts:
1. The "Boom and Bust" Dance (Cyclical Growth)
The researchers noticed that the field doesn't just grow in a straight line. It moves in cycles, like a heartbeat or the tides. They identified three distinct "eras" in this 25-year period:
- The Early Days (2000–2008): This was the "Low-Alignment" phase. Imagine a group of people trying to build a house but everyone is using different tools and speaking different languages. There was some activity, but it wasn't very coordinated.
- The First Wave (2009–2017): Suddenly, everyone started singing from the same songbook. Funding, collaboration, and the number of papers all grew together in a synchronized "First Wave." It was a time of expansion and excitement.
- The Second Wave (2018–Present): This is the current era. It's the biggest wave yet, with the most papers and the most collaboration. However, the researchers noticed something interesting: the field is getting more specialized. It's like the construction crew has split into highly specialized teams (one for plumbing, one for electrical, one for framing). While this means they are getting very good at specific tasks, the teams are starting to work in their own little bubbles, less connected to each other than before.
The authors compare this pattern to a design thinking process:
- Define: Figuring out what the problem is (Early Days).
- Ideate: Coming up with lots of ideas and expanding rapidly (First Wave).
- Test: Narrowing down to specific, rigorous tests and refining the details (Second Wave).
They suggest we might be at the end of this "Testing" phase and are about to start a new cycle of reflection before the next big boom.
2. The Map of Topics (What are they studying?)
The authors used a high-tech "theme detector" (a type of AI) to read all those 70,000 papers and group them by what they were actually talking about. They found five main pillars holding up the field:
- The Cancer Types: Which specific cancers are being treated? (Lung, breast, liver, etc.)
- The Support Crew: How do we help patients feel better? (Managing pain, nausea, sleep, and stress).
- The Mechanics: How does TCM actually work inside the body? (Looking at cells, DNA, and chemical reactions).
- The Results: Did it work? (Survival rates, treatment planning, and patient satisfaction).
- The Tools: How are we doing the research? (Statistics, imaging, and study design).
The Big Picture: The research is very patient-centered. It's not just about killing the cancer; it's heavily focused on keeping the patient comfortable and improving their quality of life while they undergo radiation.
3. The "Hype" Factor (Reporting Bias)
This is perhaps the most surprising finding. The authors used an AI to read the "conclusions" of the abstracts (the short summaries at the start of papers) to see how the results were described.
They found a massive, consistent bias toward positivity.
- Whether the study was about a specific cancer, a specific drug, or a specific year, about 70% of the reported results were framed as "positive" or "successful."
- Only about 15% were framed as "negative" or "failed."
- This happened regardless of whether the study was a simple lab experiment or a complex human trial.
The Metaphor: Imagine a sports team where the coach only talks about the wins in the press conference and never mentions the losses, even if the team lost half their games. The paper suggests that the scientific community studying TCM and radiation is doing something similar. They aren't necessarily lying, but they are consistently choosing to highlight the good news and downplay the bad news in their summaries. This is a "system-wide" habit, not just a few bad actors.
4. The Mainstream Shift
In the early days, TCM research was mostly published in niche, specialized journals. Now, the "support crew" has moved into the mainstream.
- Top, general medical journals (like PLoS ONE and Scientific Reports) are publishing these studies.
- The research is no longer just happening in China; it's a global effort involving the US, Europe, and Asia working together.
- The US used to lead the way, but China has recently taken the lead in the number of papers published.
The Bottom Line
The paper concludes that TCM as a partner to radiation therapy has matured. It has moved from a scattered, experimental phase to a highly organized, specialized, and mainstream field.
However, there are two warnings on the horizon:
- Fragmentation: The field is splitting into too many specialized silos, which might make it harder for the different teams to talk to each other.
- Optimism Bias: The field is very good at reporting success, but it might be too good at hiding the failures. To truly understand if this approach works, the scientific community needs to be more honest about the "mixed" or "negative" results, not just the wins.
In short: The field is bigger, better organized, and more popular than ever, but it needs to make sure it's telling the whole story, not just the happy parts.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.